Joint Position Statement regarding GLP-1/GIP Receptor Agonists in people living with obesity and/or type 2 diabetes

Our position statements set out our views on an important area in nutrition and may provide guidance to researchers, regulatory agencies and policy makers, health professionals, the food industry and the media. This position statement was produced by expert nutrition scientists representing both organisations and reviewed by the British Nutrition Foundation’s Scientific Committee and BDA's specialist obesity and diabetes groups.

Related topics